Berkshire Biomedical

About:

Berkshire Biomedical is a digital health company developing a revolutionary virtual care and prescription drug management system.

Website: https://www.berkshirebiomedical.com/

Top Investors: National Institute on Drug Abuse (NIDA)

Description:

Berkshire Biomedical, LLC is a healthcare solutions provider focused on impacting lives by leveraging technology to improve medical outcomes and enhance patient wellness. The Company's lead product under development, the (COPA™) System, is designed to address the intersection of two significant needs in the healthcare delivery system: virtual care delivery using technology combined with data and medication self-administration and adherence.

Total Funding Amount:

$5.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2016-01-01

Contact Email:

bdunn(AT)berkbiomed.com

Founders:

Susan Owen, Thomas M. Rouse

Number of Employees:

11-50

Last Funding Date:

2022-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai